Agilon Health Inc.
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the com...
Latest News
10 days ago · zacks.com
Are Medical Stocks Lagging Agilon Health (AGL) This Year?Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.
26 days ago · zacks.com
Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?Here is how Agilon Health (AGL) and CRISPR Therapeutics AG (CRSP) have performed compared to their sector so far this year.
28 days ago · businesswire.com
agilon health Sets Date to Report Third Quarter 2026 Financial ResultsWESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will release financial results for the third quarter 2026 after market close on Wednesday, November 4, 2026 and host a conference call at 4:30 p.m. ET to discuss the results. The conference call can be accessed by dialing (833) 461-5787 for U.S. participants and +1 (585) 542-9983 for international participants and ref.
2 months ago · businesswire.com
agilon health and Family Practice Center Expand Relationship Through Senior Health Connect ACOWESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the expansion of its relationship with Family Practice Center, PC (FPC) in Pennsylvania, which will join one of agilon's Senior Health Connect Accountable Care Organizations (ACOs). Family Practice Center, central Pennsylvania's largest independent primary care physician group serving more than 200,000 patients, entered into a long.
2 months ago · zacks.com
Is Agilon Health (AGL) Outperforming Other Medical Stocks This Year?Here is how Agilon Health (AGL) and Illumina (ILMN) have performed compared to their sector so far this year.
2 months ago · businesswire.com
agilon health Announces Revised Presentation Time at the 2026 Jefferies Healthcare Services and Technology ConferenceWESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will now participate in a fireside chat at the 2026 Jefferies Healthcare Services and Technology Conference at 4:00pm ET on Monday, September 14, 2026. Interested investors and other parties may listen to a simultaneous webcast of the presentation by visiting the “Events & Presentations” section o.
2 months ago · businesswire.com
agilon health to Participate in Upcoming ConferencesWESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that its management team will participate in a fireside chat at the following conferences: Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. 2026 Jefferies Healthcare Services and Technology Conference on Monday, September 14, 2026. A live webcast will be available on the company's investor relati.
3 months ago · zacks.com
Has Agilon Health (AGL) Outpaced Other Medical Stocks This Year?Here is how Agilon Health (AGL) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
3 months ago · reuters.com
Australia's AGL Energy logs nearly 2% fall in annual profitAustralian power producer AGL Energy reported a nearly 2% fall in its annual underlying profit on Wednesday, pressured by higher gas supply costs and lower wholesale electricity prices.
3 months ago · seekingalpha.com
agilon health: The Q2 Inflection Is Realagilon Health delivered a strong Q2 2026 with revenue of $1.49B, a $250M YoY medical margin swing, and raised FY26 guidance across all key metrics. AGL's operational turnaround is supported by improved cost trends, enhanced data pipelines, and clinical pathway execution, notably reducing inpatient first-diagnosis rates from 25% to under 5%. Balance sheet strength is evident with over $220M net cash, while disciplined membership management supports ongoing profitability.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove AGL